Global Antimicrobial Wound Dressings Market Trends, Forecast Report 2025-2037
Antimicrobial Wound Dressings Market size is anticipated to expand from USD 1.81 billion to USD 4.1 billion, exhibiting a CAGR of around 6.5% during the forecast timeline, from 2025 to 2037. In the year 2025, the industry size of antimicrobial wound dressings is evaluated at USD 1.9 billion.
The market is expanding due to rising prevalence of chronic wounds. For instance, it is speculated that over 13 million people worldwide suffer from chronic wounds each year, with the number of sufferers increasing as the population ages. Antibacterial wound dressings contain agents or compounds with antibacterial characteristics, such as silver, iodine, and PHM. Antimicrobial wound dressings, which act as a barrier against microorganisms, can minimize the risk of infection and facilitate healing. Therefore, the global frequency of chronic wounds is predicted to rise, increasing the demand for antimicrobial wound dressings.
In addition, the antimicrobial wound dressings market growth is owing to improved understanding of the wound healing process and technological advancements, there have been noteworthy advances in wound treatment. Along with this, dressings made from natural and synthetic sources are currently gaining popularity. Plant extracts have been successfully studied in injectable forms for adult stem cell therapies, and they have been shown to aid in skin regeneration when used in dressings.
.webp)
Antimicrobial Wound Dressings Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing surgical interventions - Surgical treatments, both elective and emergency, increase demand for wound products, such as antimicrobial dressings. The increase in surgical treatments, particularly in fields such as orthopedics and cardiovascular surgery, helps to drive antimicrobial wound dressings market growth. Following surgical operations, patients are frequently left with surgical wounds that require adequate care and management to promote healing and prevent infection.
Antimicrobial wound dressings are vital for this reason because they help to maintain a clean environment around the wound, lowering the incidence of surgical site infections (SSIs). As a result, the market for antimicrobial wound dressings has grown. - Increasing geriatric population - Chronic wounds, such as pressure ulcers and venous leg ulcers, become more common as the population ages. Older persons are more vulnerable to chronic wounds for a variety of reasons, including limited mobility, impaired circulation, and comorbidities including diabetes and cardiovascular disease. As a result, antimicrobial wound dressings are becoming more widely used.
According to a report, the proportion of persons aged 65 and up is growing faster than those under that age. This means that the proportion of the global population aged 65 and more is predicted to climb from 10% in 2022 to 16% by 2050. Therefore, the increasing geriatric population is influencing the market growth. - Surge in the adoption of advanced wound dressing technologies - The market for antimicrobial wound dressings is just as dynamic as any other. Wound dressings have evolved, including innovative technologies such as smart sensors and microelectronics. These technologies allow for continuous monitoring of the wound healing process and infection status, delivering real-time data to healthcare providers.
Furthermore, the industry's leading players are continually launching new products, fueling market growth. For instance, Convatec has launched ConvaFoam™ in the US, offering improved foam dressings for healthcare practitioners and patients. ConvaFoam™ is a versatile dressing that may be applied to many wound types at any point of the healing process, making it the ideal solution for wound management and skin protection.
Challenges
- High costs of the product - Antimicrobial wound dressings are typically more expensive than regular wound dressings. The additional cost can be prohibitive for healthcare systems and people, particularly in areas with limited healthcare budgets. As a result, the antimicrobial wound dressings market may experience a decline.
- Reduced healthcare spending in developing nations may hinder market growth
- Inaccessible treatment for a large number of patients may act as a market restrain
Antimicrobial Wound Dressings Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.5% |
|
Base Year Market Size (2024) |
USD 1.81 billion |
|
Forecast Year Market Size (2037) |
USD 4.1 billion |
|
Regional Scope |
|
Antimicrobial Wound Dressings Segmentation
Application (Chronic Wounds, Acute Wounds)
The chronic wounds segment in the antimicrobial wound dressings market is set to account for 58% revenue share by 2037. The dominance can be linked to an increase in the number of persons suffering from chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other types. Diabetes, cancer, and other autoimmune illnesses are expected to increase the incidence rate of chronic wounds all over the world. Diabetes risk factors include age, diet, physical activity, obesity, and genetics.
High blood sugar levels, poor circulation, immune system issues, and nerve damage can all increase the risk of developing a chronic wound, such as a diabetic foot ulcer. For instance, approximately 25% of patients with diabetes will develop a foot ulcer. A foot ulcer is the starting point for 85% of diabetic amputations. Also, neuropathy, peripheral arterial disease (PAD), deformities, and Charcot's foot are all risk factors for developing diabetic foot ulcers.
Product (Silver Dressings, Povidone-iodine Dressings, PHMB Dressings)
The silver dressings segment is predicted to hold a substantial share of 50% during the forecast timeline. The segment growth is driven by growing demand for the treatment of infections and wounds. Silver wound dressings are antimicrobial wound dressings using silver as an active ingredient. The dressing acts by releasing silver ions, which help to kill or inhibit the development of bacteria in the wound bed. In the treatment of chronic wounds that are prone to infection, such as pressure ulcers and diabetic foot ulcers, silver wound dressing is helpful. They are also used to treat surgical wounds, lowering the risk of infection and promoting speedier recovery.
Our in-depth analysis of the market includes the following segments:
|
Product |
|
|
Application |
|
|
End-use |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportAntimicrobial Wound Dressings Industry - Regional Synopsis
North America Market Statistics
Antimicrobial Wound Dressings market in the North America is set to hold the largest with a share of about 37% by the end of 2037. The market growth in the region is driven by large aging population, increased wound and injury rates, and a high incidence of diabetes. According to a report, chronic wounds afflict around 8.2 million people in the United States every year.
Additionally, the market expansion is due to rising healthcare costs and expanded government support and reimbursement schemes for goods. Moreover, North America has well-established healthcare legislation and infection control requirements, making antimicrobial dressings an appealing option for healthcare professionals. These criteria place a high priority on avoiding surgical site infections, pressure ulcers, and other problems that can be treated with antimicrobial dressings.
APAC Market Analysis
The APAC region will also witness gigantic growth for the antimicrobial wound dressings market during the forecast period, owing to expanding population in the region. Furthermore, medical tourism and an increase in severe wounds are major factors augmenting the market growth in the region. Antimicrobial wound dressings may also become more popular as chronic diseases and surgical cases increase in the Asia-Pacific region.
.webp)
Companies Dominating the Antimicrobial Wound Dressings Landscape
- Bactiguard
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medline Industries
- Smith & Nephew
- Cardinal Health
- Convatec, Inc.
- B. Braun SE
- Coloplast Corp.
- McKesson Corporation
- Paul Hartmann AG
- 3M
In the News
- Bactiguard announced the debut of its wound offering in the United Kingdom and Ireland, in conjunction with Quintess Medical and their full-service medical sales and distribution partner, GS Medical. The agreement will not only expand Bactiguard's wound-care product line to reach more patients and end-users but will also boost Bactiguard's position in the wound-care industry. The UK wound market was valued at roughly GBP 860 million in 2022 and is predicted to expand in the future years.
- Medline, the industry leader in skin care, unveiled the latest addition to its advanced wound portfolio, the OptiView® Transparent Dressing with HydroCore™ Technology. This unique clear wound dressing allows caregivers to quickly and easily inspect, monitor, and blanch skin while the covering is in place.
Author Credits: Radhika Pawar
- Report ID: 2856
- Published Date: Jan 28, 2025
- Report Format: PDF, PPT
